INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | 930 วันที่ผ่านมา
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For  Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

แท็ก : INO
read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 568 วันที่ผ่านมา
European Shares Rise On Trade Deal Hopes

European Shares Rise On Trade Deal Hopes

European stocks opened higher on Wednesday amid expectations of a potential trade deal with the United States.
RTTNews | 16 นาทีที่ผ่านมา
German Economy Recovers On Spending, Investment

German Economy Recovers On Spending, Investment

The German economy recovered in the first quarter driven by higher private consumption and investment, flash data from Destatis revealed on Wednesday. Gross domestic product grew 0.2 percent sequentially, offsetting the 0.2 percent fall in the preceding quarter. The rate also matched economists' expectations. The calendar-adjusted GDP posted an annual fall of 0.2 percent.
RTTNews | 1 ชม. 0 นาทีที่ผ่านมา